Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cryptococcal meningoencephalitis: time for action.
Lancet Infect Dis. 2021 Sep;21(9):e259-e271. doi: 10.1016/S1473-3099(20)30771-4. Epub 2021 Apr 16.
Lancet Infect Dis. 2021.
PMID: 33872594
Review.
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.
Lawrence DS, et al. Among authors: alufandika m.
Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4.
Trials. 2018.
PMID: 30470259
Free PMC article.
Item in Clipboard
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.
Lawrence DS, et al. Among authors: alufandika m.
Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9.
Trials. 2019.
PMID: 30642386
Free PMC article.
Item in Clipboard
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
Ponatshego PL, Lawrence DS, Youssouf N, Molloy SF, Alufandika M, Bango F, Boulware DR, Chawinga C, Dziwani E, Gondwe E, Hlupeni A, Hosseinipour MC, Kanyama C, Meya DB, Mosepele M, Muthoga C, Muzoora CK, Mwandumba H, Ndhlovu CE, Rajasingham R, Sayed S, Shamu S, Tsholo K, Tugume L, Williams D, Maheswaran H, Shiri T, Boyer-Chammard T, Loyse A, Chen T, Wang D, Lortholary O, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, Niessen LW.
Ponatshego PL, et al. Among authors: alufandika m.
BMJ Open. 2019 Apr 1;9(4):e026288. doi: 10.1136/bmjopen-2018-026288.
BMJ Open. 2019.
PMID: 30940760
Free PMC article.
Clinical Trial.
Item in Clipboard
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
Alufandika M, Lawrence DS, Boyer-Chammard T, Kanyama C, Ndhlovu CE, Mosepele M, Tugume L, Meya D, Boulware DR, Rhein J, Muzoora C, Youssouf N, Molloy SF, Schutz C, Lortholary O, Meintjes G, Mwandumba HC, Harrison TS, Jarvis JN; and the AMBITION-cm Study Group.
Alufandika M, et al.
AIDS. 2020 Jul 15;34(9):1425-1428. doi: 10.1097/QAD.0000000000002556.
AIDS. 2020.
PMID: 32590438
Free PMC article.
No abstract available.
Item in Clipboard
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study.
Gupta-Wright A, Fielding K, van Oosterhout JJ, Alufandika M, Grint DJ, Chimbayo E, Heaney J, Byott M, Nastouli E, Mwandumba HC, Corbett EL, Gupta RK.
Gupta-Wright A, et al. Among authors: alufandika m.
Lancet HIV. 2020 Sep;7(9):e620-e628. doi: 10.1016/S2352-3018(20)30172-7.
Lancet HIV. 2020.
PMID: 32890497
Free PMC article.
Item in Clipboard
Cite
Cite